A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Phase 2 Terminated
50 enrolled 18 charts
AcceleRET-Lung
Phase 3 Terminated
223 enrolled 18 charts
Pembro+Chemo in Brain Mets
Phase 2 Terminated
3 enrolled 7 charts
Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Phase 1/2 Terminated
137 enrolled 31 charts
A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer
Phase 1/2 Terminated
10 enrolled
Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET
Phase 2 Terminated
20 enrolled
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
1 enrolled 4 charts
FORTITUDE-201
Phase 1 Terminated
74 enrolled 22 charts
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer
Phase 1/2 Terminated
36 enrolled 26 charts
A Study of Sargramostim Plus Pembrolizumab with or Without Pemetrexed in Patients with Advance Non-small Cell Lung Cancer After Completion of Chemoimmunotherapy
Phase 2 Terminated
5 enrolled
A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC
Phase 3 Terminated
8 enrolled 6 charts
Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer
Phase 3 Terminated
8 enrolled 7 charts
SUMMIT
Phase 2 Terminated
582 enrolled 27 charts
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Terminated
153 enrolled 13 charts
CanStem43L
Phase 3 Terminated
4 enrolled 6 charts
Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer
Phase 2 Terminated
7 enrolled 12 charts
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Phase 3 Terminated
1,333 enrolled 22 charts
Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 1 Terminated
16 enrolled
PROPEL
Phase 1/2 Terminated
162 enrolled 21 charts
PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients
Phase 1 Terminated
111 enrolled
Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer
Phase 1/2 Terminated
28 enrolled
Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC
Phase 2 Terminated
4 enrolled 6 charts
MnSOD
Phase 1/2 Terminated
18 enrolled 12 charts
ATRACT-1
Phase 3 Terminated
1,285 enrolled
A Study of Carboplatin and Paclitaxel With or Without MEDI-575 in Untreated, Advanced Non-Small Cell Lung Cancer
Phase 1/2 Terminated
99 enrolled 30 charts
PIONEER
Phase 3 Terminated
600 enrolled
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Phase 3 Terminated
450 enrolled
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Phase 1 Terminated
17 enrolled
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Phase 2 Terminated
66 enrolled 17 charts
UF-STO-LUNG-002
Phase 1/2 Terminated
3 enrolled 8 charts
TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy
Phase 3 Terminated
149 enrolled 17 charts
Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Phase 2 Terminated
59 enrolled 16 charts
Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors
Phase 1 Terminated
9 enrolled 14 charts
Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer
Phase 3 Terminated
2 enrolled 6 charts
Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery
Phase 2 Terminated
2 enrolled 4 charts
Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer
Phase 2 Terminated
7 enrolled
Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
Phase 2 Terminated
25 enrolled 9 charts
Paclitaxel Detection in NSCLC Treated With TC Regimen
Phase 2 Terminated
51 enrolled
AZD2014 and Weekly Paclitaxel in Squamous NSCLC
Phase 2 Terminated
11 enrolled 12 charts
Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
Phase 2 Terminated
175 enrolled 8 charts
HySBst
Phase 1 Terminated
1 enrolled
HCH003
Phase 1/2 Terminated
7 enrolled
A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC
Phase 2 Terminated
186 enrolled
Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 2 Terminated
16 enrolled 11 charts
NRR
Phase 2 Terminated
30 enrolled 12 charts
Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery
Phase 1/2 Terminated
5 enrolled 11 charts
Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer
Phase 1/2 Terminated
8 enrolled 6 charts
INNOVATE
Phase 2 Terminated
10 enrolled
A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology
Phase 1/2 Terminated
12 enrolled
TIME
Phase 2/3 Terminated
222 enrolled